Bli medlem
Bli medlem

Du är här


FIT Biotech Oy: FIT Biotech will publish half-year financial report on September 14, 2016


Company announcement
September 5, 2016 at 15:15 EET

FIT Biotech will publish half-year financial report on September 14, 2016

FIT Biotech Oy will publish half-year financial report already on September
14, 2016 instead of September 15, 2016 as earlier announced.

FIT Biotech's Extraordinary General Meeting (EGM) will be held on September
15, 2016 starting at 11:00 as informed in the company's announcement
published on August 25, 2016.

Further information:
Chairman of the Board, Juha Vapaavuori
Tel: +358 50 372 0824

Certified Advisor: Translink Corporate Finance Oy, tel. +358 20 743 2790

FIT Biotech in brief
FIT Biotech Oy is a biotechnology company established in 1995 that develops
and licenses its patented GTU® (Gene Transport Unit) vector technology for
new-generation medical treatments. GTU® is a gene transport technology that
meets an important medical challenge in the usability of gene therapy and DNA

FIT Biotech applies GTU® technology in its drug development programmes.
Application areas include cancer (gene therapy) and infectious diseases such
as HIV and tuberculosis, as well as animal vaccines.
FIT Biotech shares are listed on the First North Finland market maintained by
Nasdaq Helsinki Oy.

Nasdaq Helsinki
Principal media


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: FIT Biotech Oy via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.